Clinical Trial Update: Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating Arfolitixorin as rescue therapy for osteosarcoma patients receiving high-dose methotrexate; study completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Arfolitixorin (arfolitixorin)

Snippet

Sponsor: Isofol Medical AB | Conditions: Osteosarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-06-26